Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.

Biotechnology

Health Care

Therapeutics

Nitrase Therapeutics

Frank Kayser

Irene Griswold-Prenner

Sheerin Shahidi-Latham

Arun Kashyap

Carla Ramos

Research and Development

Leadership Team

Teams at Nitrase Therapeutics

Research and Development

Leadership Team